Indefinite Delivery Contract 75N92023D00013

Award Date 9/12/23
Last Date to Order 9/11/33
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The National Heart, Lung and Blood Institute, part of the National Institutes of Health and Department of Health and Human Services, awarded a single award Indefinite Delivery Contract to New York Genome Center, Inc. doing business as Nygc. The potential value of the contract is $500 million to be ordered through September 2033. A firm fixed price delivery order for $742,360 was also awarded for RNA-Seq services to support the Trans-Omics for Precision Medicine initiative's Centralized Omics...
The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Psomagen Inc., a subsidiary of Macrogen, Inc., with a potential value of $500 million. The contract supports the Trans-Omics for Precision Medicine initiative through September 2033 by providing complex data analysis, integration, and management of large-scale genomic and health datasets. Specifically, the contractor will establish and operate the Centralized Omics Resource to perform...
The National Heart, Lung and Blood Institute awarded Baylor College of Medicine a single award indefinite delivery contract with a potential value of $500 million to provide Trans-Omics for Precision Medicine Centralized Omics Resource services. Under the originating contract, Baylor College of Medicine was issued a firm fixed price delivery order valued at $14.46 million to perform Task Areas 2, 3 and 4. These task areas include omics data generation, analysis and storage in support of the...
The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Cedars-Sinai Medical Center to establish the Centralized Omics Resource for its Trans-Omics for Precision Medicine initiative. With a potential value of $500 million, this IDV enables task orders to be placed through September 2033 for complex data analysis, integration and management of large-scale genomic and health datasets to support the initiative's goals. The originating pre-solicitation...
The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services awarded a single award indefinite delivery contract to the University of Washington with a potential value of $500 million. The contract provides for Centralized Omics Resource DNA methylation services to support the Trans-Omics for Precision Medicine initiative through September 2033. A firm fixed price delivery order for $2.99 million was issued against this contract to...
This indefinite delivery contract, awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the Department of Health and Human Services, provides for a Centralized Omics Resource (CORE) to support the Trans-Omics for Precision Medicine (TOPMed) initiative. The multiple-award contract has a total ceiling value of $505,000,000 and a period of performance through September 2033. Cedars-Sinai Medical Center, a non-profit academic medical center, was selected as a prime...
The National Heart, Lung and Blood Institute awarded a single-award indefinite delivery contract to Vanderbilt University Medical Center to establish the Centralized Omics Resource for its Trans-Omics for Precision Medicine initiative. This IDV has a potential value of $500 million and a period of performance through September 2033. The purpose of the contract is to provide complex data analysis, integration, and management of large-scale genomic and health datasets to support the Trans-Omics...
The National Heart, Lung and Blood Institute (NHLBI) has awarded a $500,000,000 Indefinite Delivery Contract (IDC) to Stanford University to establish the Centralized Omics Resource for the Trans-Omics for Precision Medicine (TOPMed) initiative. This single-award IDC, which runs through September 2033, tasks Stanford with providing data analysis, integration, and management services for omics and health data to support NIH's precision medicine efforts. The original pre-solicitation notice sought...
This indefinite delivery contract (IDC) was awarded by the National Heart, Lung, and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services, to the Altius Institute for Biomedical Sciences, a non-profit organization. The $505 million contract, known as the Centralized Omic REsource for TOPMed (CORE), has a period of performance from September 2016 to September 2021. The purpose of the CORE contract is to provide a centralized resource for omic (genetic,...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute (NHLBI) awarded a $8,803,200.00 Delivery Order contract to Precision For Medicine, Inc., a for-profit organization, for a Biologic Specimen Repository. The contract is cost-plus-award-fee and runs from April 1, 2024 to March 31, 2029. Precision For Medicine, Inc. is an experienced provider of biorepository services, having previously supported repositories for the...
  • 75N92023D00013
    Indefinite Delivery Contract
  • 2
    Federal Contract Awards

The National Heart, Lung and Blood Institute of the National Institutes of Health, Department of Health and Human Services awarded a single award indefinite delivery contract with a potential value of $500 million to The Broad Institute, Inc., doing business as Broad Institute of MIT and Harvard. The contract aims to support the Trans-Omics for Precision Medicine initiative through the provision of genomics data generation, analysis, and management services.

Under the contract, the National Heart, Lung and Blood Institute issued a firm fixed price delivery order worth $3.6 million to The Broad Institute for Task Areas 2, 3 and 4. These tasks involve genomics data generation, analysis, and management to support large-scale studies of the role of genomics in human health and disease. The period of performance for the delivery order is from September 2023 through September 2024 and places of performance include Cambridge, Massachusetts.

No set-asides were used for either the indefinite delivery contract or associated delivery order. The original pre-solicitation sought capability information for potential requirements to support the Trans-Omics for Precision Medicine initiative through a questionnaire addressing complex data analysis, integration and management of large scale genomic and health datasets.

Generated 1/4/24, 10:28 PM